Plasmodium falciparum malaria
Plasmodium falciparum malaria
Explore linked clinical trials. Standard reference: MONDO:000592046 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT02471378 | |
| First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-10-05 | NCT07646353 | |
| Infant Malaria Vaccine Schedule Optimization | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-09-29 | NCT06879327 | |
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not stated | 2026-09-25 | NCT07840898 | |
| Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 Years | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07831226 | |
| IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Not applicable | 2026-09-22 | NCT06870344 | |
| Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-09-18 | NCT06923592 | |
| Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-15 | NCT07819825 | |
| Platelet-Directed Whole Blood Transfusion Strategy for Malaria | Cytopenia, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, blood platelet disease, hematologic disorder, malaria, parasitic infectious disease, protozoa infectious disease, thrombocytopenia, vector-borne disease | Recruiting | Not applicable | 2026-09-11 | NCT05711485 | |
| Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2) | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-09-10 | NCT07811908 | |
| Malaria CVD 36000; Gates INV090205 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-09 | NCT07558122 | |
| OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren | Hemic and Lymphatic Diseases, Infections, Inflammation, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium falciparum malaria, anemia, hematologic disorder, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 3 | 2026-09-01 | NCT07798583 | |
| Dose Finding Trial of R21/Matrix-M in School Children | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-08-24 | NCT07074665 | |
| Insecticide-Treated Baby Wraps for the Prevention of Malaria | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not applicable | 2026-08-19 | NCT07773350 | |
| Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT) | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-08-06 | NCT07749911 | |
| R21/MM Dosing, Presentations, and Preservatives | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 4 | 2026-08-04 | NCT07194668 | |
| Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-07-31 | NCT07730177 | |
| PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-07-23 | NCT07675785 | |
| A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 2 | 2026-07-08 | NCT07545681 | |
| Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-06-29 | NCT07559370 | |
| DON in Pediatric Cerebral Malaria | Central Nervous System Parasitic Infections, Central Nervous System Protozoal Infections, Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, central nervous system disorder, central nervous system infectious disorder, cerebral malaria, malaria, nervous system disorder, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT05478720 | |
| Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-06-22 | NCT06862453 | |
| Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-06-15 | NCT07011511 | |
| Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 2 | 2026-06-01 | NCT07385287 | |
| Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics | Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Infections, Mosquito-Borne Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium falciparum malaria, Premature Birth, Urogenital Diseases, malaria, parasitic infectious disease, pregnancy disorder, pregnancy disorder with abortive outcome, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 4 | 2026-05-07 | NCT05757167 |